We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$2.53B
Cap. Flow
+$1B
Cap. Flow %
7.59%
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$120M
2
GL icon
Globe Life
GL
+$115M
3
MPT
Medical Properties Trust
MPT
+$91.5M
4
ACGL icon
Arch Capital
ACGL
+$69.2M
5
AMZN icon
Amazon
AMZN
+$45.6M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$138M
2
GSK icon
GSK
GSK
+$98.7M
3
CCK icon
Crown Holdings
CCK
+$92.3M
4
AWK icon
American Water Works
AWK
+$54M
5
SEDG icon
SolarEdge
SEDG
+$45.7M

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Financials 15.05%
3 Healthcare 13.07%
4 Consumer Discretionary 9.61%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDY icon
2976
Dr. Reddy's Laboratories
RDY
$10.2B
-920
Closed -$12K
RIG icon
2977
Transocean
RIG
$5.82B
$0 ﹤0.01%
348
RLMD icon
2978
Relmada Therapeutics
RLMD
$527M
$0 ﹤0.01%
27
RMBS icon
2979
Rambus
RMBS
$11B
-35
Closed
ROM icon
2980
ProShares Ultra Technology
ROM
$1.29B
-1,200
Closed -$34K
RPG icon
2981
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
-70
Closed -$1K
RYAM icon
2982
Rayonier Advanced Materials
RYAM
$610M
-5,000
Closed -$16K
SANM icon
2983
Sanmina
SANM
$10.9B
-50
Closed -$1K
SCS
2984
DELISTED
Steelcase
SCS
-78
Closed
SHG icon
2985
Shinhan Financial Group
SHG
$35.6B
-26
Closed
SKY icon
2986
Champion Homes
SKY
$5.14B
$0 ﹤0.01%
+26
New +$766
SNOA icon
2987
Sonoma Pharmaceuticals
SNOA
$6.89M
$0 ﹤0.01%
4
SPMD icon
2988
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
$0 ﹤0.01%
11
-17
-61% -$630
SSKN
2989
DELISTED
Strata Skin Sciences
SSKN
$0 ﹤0.01%
+45
New +$648
SSTK icon
2990
Shutterstock
SSTK
$219M
-290
Closed -$15K
STRA icon
2991
Strategic Education
STRA
$1.92B
-136
Closed -$12K
SUPN icon
2992
Supernus Pharmaceuticals
SUPN
$2.77B
-315
Closed -$6K
SWX icon
2993
Southwest Gas
SWX
$6.67B
$0 ﹤0.01%
+13
New +$856
TCRT icon
2994
Alaunos Therapeutics
TCRT
$4.86M
-102
Closed -$38K
TECK icon
2995
Teck Resources
TECK
$32.6B
-275
Closed -$3K
TKC icon
2996
Turkcell
TKC
$4.79B
$0 ﹤0.01%
+56
New +$282
TRMK icon
2997
Trustmark
TRMK
$2.75B
-23
Closed
TTGT icon
2998
TechTarget
TTGT
$278M
-72
Closed -$3K
TTNP
2999
DELISTED
Titan Pharmaceuticals
TTNP
0
TYG
3000
Tortoise Energy Infrastructure Corp
TYG
$1.08B
-500
Closed -$7K

Similar funds

Rockefeller Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.

  • Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
  • Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
  • Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
  • Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
  • Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
  • Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
  • Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.